Research services to develop and expand the FDA ARGOS
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- OC Acquisition Liaison ocacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration seeks research services to develop and expand the FDA ARGOS platform through bioinformatic and biological research capabilities. This requirement involves creating a repository and database of high-quality, regulatory-grade next-generation sequences designed to support the development of diagnostics and medical countermeasures. The solicitation is expected to be released on January 1, 2026, with an estimated award date of July 1, 2026.
The estimated award value ranges from $250,000 to $700,000, with work classified under NAICS code 541714 (Research and Development in Biotechnology, except Nanobiotechnology). This is a follow-on requirement based on early engagement activities conducted in FY2025 and represents a new requirement with no set-aside used. For inquiries and submissions, interested parties should contact the FDA's Office of Acquisition at ocacquisitions@fda.hhs.gov.
Forecast text
Requirement is a follow-on for early engagement conducted in FY2025, entailing research services for bioinformatic and biological research to develop a repository/database of high quality regulatory grade next generation sequences to support development of diagnostics and medical countermeasures.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast